Jordan Karp is a Psychiatry physician. OpenAlex indexes 275 publications with 7,665 citations (h-index 46); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3811 Ohara St
Bt 7th Floor
Pittsburgh, PA 152132593
Telephone
412-246-6048Registry record last updated 8 Jul 2007.
Clinical trials
- Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine
Sponsor: Jordan F. Karp
- RAPID: Reducing Pain; Preventing Depression
Sponsor: University of Pittsburgh
- Buprenorphine for Treatment Resistant Depression
Sponsor: University of Pittsburgh
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Scientific Affairs, LLCProgram year202514 payments
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20251 payment
- Novo Nordisk IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
4 NIH research awards on record, funded 2010–2019 per NIH RePORTER. The latest:
- 3/5 Neurocognitive and neuroimaging biomarkers: predicting progression towards dementia in patients with treatment resistant late-life depression
University of Pittsburgh at Pittsburgh
FY2019$380,830R01MH114969 - 1/3 Buprenorphine for Late-Life Treatment Resistant Depression
University of Pittsburgh at Pittsburgh
FY2016$223,969R34MH101371 - 1/3 Buprenorphine for Late-Life Treatment Resistant Depression
University of Pittsburgh at Pittsburgh
FY2015$223,969R34MH101371
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression
New England Journal of Medicine
2023 - Efficacy of Blended Collaborative Care for Patients With Heart Failure and Comorbid Depression
JAMA Internal Medicine
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”